Pfenex Revenue and Competitors
Estimated Revenue & Valuation
- Pfenex's estimated annual revenue is currently $35M per year.
- Pfenex's estimated revenue per employee is $2,058,824
- Pfenex's total funding is $63.4M.
Employee Data
- Pfenex has 17 Employees.
- Pfenex grew their employee count by -11% last year.
Pfenex's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Finance and Controller | Reveal Email/Phone |
2 | Director, Purification Development and Lab Operations | Reveal Email/Phone |
3 | Associate Director, Product Development Leader | Reveal Email/Phone |
4 | Director Manufacturing / Technology Transfer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Director, Portfolio Development | Reveal Email/Phone |
7 | Scientist-Downstream Processing | Reveal Email/Phone |
Pfenex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $69340M | 107310 | 4% | N/A | $308.4B |
What Is Pfenex?
Headquartered in San Diego, California, Pfçnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfçnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfçnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein
keywords:N/A$63.4M
Total Funding
17
Number of Employees
$35M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pfenex News
... Pangen Biotech Inc., Pfenex Inc, Pfizer Inc, Reliance Life Sciences Pvt Ltd, Richter Gedeon Nyrt, Sandoz International GmbH, USV Pvt Ltd.
Shire; Bayer; Genentech; Pfenex; Reliance Life Sciences; Hetero Drugs; Intas Pharmaceuticals; Santo Holding; Regeneron Pharmaceuticals. The...
... Deal Terms and Agreements Analysis Report 2021 with Example Case Studies of Agila Specialties/Pfenex and Dance Biopharm/Harmony Asset.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 17 | 6% | $21.4M |
#2 | $3.6M | 17 | N/A | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |